Is a high reverse T3 dangerous?

No. Reverse T3 is an inactive metabolite that the body makes and clears every day. A high value usually reflects illness, fasting, a medication, or simply a higher T4 supply from levothyroxine. It is a signal of those states, not a disease in itself.

Should I ask my doctor for a reverse T3 test?

For routine hypothyroidism care, the American Thyroid Association says the test is not clinically useful in non-hospitalized people. TSH and free T4 answer the main questions. If your symptoms persist with a normal TSH, ask about dose timing, absorption, and other causes instead.

Can a low-calorie diet raise reverse T3?

Yes. Starvation and carbohydrate restriction rapidly reduce type 1 deiodinase activity in the liver. That lowers T3 production and slows the clearance of reverse T3, so rT3 rises. The change is an adaptive response to low energy intake, and it reverses when normal eating resumes.

Does levothyroxine itself increase reverse T3?

It can. Levothyroxine is T4, and about one third of T4 breakdown normally goes to reverse T3. A 2025 study found elevated rT3 more often in people taking levothyroxine than in untreated people. That reflects the extra T4 supply and has not been shown to cause symptoms.

What is the T3 to reverse T3 ratio, and is it validated?

The ratio divides free or total T3 by reverse T3. Some clinics use it to diagnose "reverse T3 dominance." No professional guideline endorses the ratio, and reviews in Thyroid and Frontiers in Endocrinology found no evidence that it should guide treatment.

What Is Reverse T3 and Does It Matter?

The short answer: Reverse T3 (rT3) is an inactive byproduct made when the body breaks down thyroxine (T4). It rises during illness, fasting, and with some drugs. In people who are not hospitalized, the test does not show whether you have hypothyroidism, and no major guideline recommends it. Symptoms with a normal TSH are real and deserve a workup, but rT3 does not explain them.

What is reverse T3?

Your thyroid mostly makes T4, a prohormone. Enzymes called deiodinases remove one iodine atom from T4. According to the Endotext chapter on thyroid hormone metabolism, roughly 80% of T3 comes from outer ring deiodination of T4 in peripheral tissues by type 1 and type 2 deiodinase. Type 3 deiodinase (D3) removes an iodine from the inner ring instead. That step turns T4 into rT3.

A 2005 review in Thyroid calls D3 "the physiologic inactivator of thyroid hormones." Its products, rT3 and T2, are biologically inactive. Endotext notes that about one third of T4 turnover goes to rT3 each day, and D1 then clears it. The American Thyroid Association (ATA) puts it plainly: "Some reverse T3 is produced normally in the body, but is then rapidly degraded." Endotext gives an adult reference range of about 14 to 30 ng/dL, with variation between labs.

When does reverse T3 go up?

rT3 rises whenever the body shifts T4 breakdown away from T3. The main triggers are:

Serious illness. A 2012 review in Frontiers in Endocrinology describes non-thyroidal illness syndrome (NTIS), also called low T3 syndrome or euthyroid sick syndrome. The pattern is low T3, high rT3, and a normal or slightly raised TSH. D3 activity is increased in the liver and muscle of sick patients.
Fasting and calorie restriction. The Endotext NTIS chapter states that starvation, and more precisely carbohydrate deprivation, rapidly inhibits D1 in the liver. That blocks T3 production and slows rT3 clearance.
Medications. The Endotext chapter on drugs and thyroid function lists several. Amiodarone inhibits D1 and D2, causing a marked fall in T3 and a rise in rT3. Glucocorticoids raise the rT3 to T4 ratio within 24 hours. Propranolol mildly blocks deiodination, with a small drop in T3 and a reciprocal rise in rT3.

Endotext sums it up: rT3 is "elevated in all circumstances that cause low serum T3 levels in the absence of obvious clinical signs of hypothyroidism." rT3 is a marker of illness or metabolic stress, not a cause of symptoms.

Why do thyroid guidelines not recommend reverse T3 testing?

Because the test has not been shown to change decisions. The ATA page on thyroid function tests says: "In healthy, non-hospitalized people, measurement of reverse T3 does not help determine whether hypothyroidism exists or not, and is not clinically useful." A 2020 report in Annals of Clinical and Laboratory Science states that "testing of rT3 is not recommended by any professional practice guidelines."

The one setting where rT3 seemed promising was the hospital. Doctors hoped it could separate a truly hypothyroid sick patient from one whose labs are only distorted by illness. A 1995 study in Thyroid reviewed 262 rT3 results in 246 hospital patients over 4 years. Hypothyroid patients with illness sometimes had a normal rT3. The author concluded that rT3 "is not reliable in distinguishing between the hypothyroid sick patient and the euthyroid sick patient."

Ordering data show the gap between use and evidence. A 2018 study in Thyroid reviewed one year of orders at a national reference laboratory: 91,767 rT3 orders among 402,386 thyroid test orders. Just 100 providers (0.1% of the total) placed 29.5% of all rT3 orders, and 60 of them were classified as functional medicine practitioners. A systematic review of Medline "found little evidence to support the high volumes of orders for rT3." In the 2020 hospital report, only 2 of 20 rT3 results changed management. For the standard workup, TSH and free T4 do the job. Our guide to thyroid blood tests explains each number.

What about "reverse T3 dominance" and "thyroid resistance"?

Some clinics describe a condition called rT3 dominance, or cellular thyroid resistance. The theory says high rT3 blocks T3 at the receptor, so cells are hypothyroid even when TSH is normal. The proposed fix is T3 medication guided by the T3 to rT3 ratio. The 2018 Thyroid study found this claim on functional medicine websites and no supporting evidence in the medical literature.

A 2019 opinion article in Frontiers in Endocrinology reviewed the question directly. It concluded: "Currently, no evidence supports the use of rT3 to monitor levothyroxine therapy, either given alone or in combination with liothyronine." A 2020 editorial on combination therapy agreed, citing "insufficient evidence to suggest that measurement of reverse T3 might be useful for guiding combination therapy."

Newer data deserve a fair reading. A 2025 study in PLOS One of 976 patients found elevated rT3 in 20.9% of those on levothyroxine alone, 9% on no thyroid medicine, and 3.5% on desiccated thyroid. That is expected chemistry: more T4 in means more rT3 out. The authors acknowledged the study had no objective measure of fatigue and could not show that rT3 caused any symptom.

Does adding T3 help when reverse T3 is high?

The 2014 ATA Guidelines for the Treatment of Hypothyroidism (Jonklaas and colleagues, Thyroid, volume 24, pages 1670 to 1751) concluded that "levothyroxine should remain the standard of care for treating hypothyroidism." It found "no consistently strong evidence for the superiority of alternative preparations" such as levothyroxine plus liothyronine or thyroid extract.

Three recommendations apply:

Recommendation 13b advises against routine combination therapy, citing conflicting randomized trial results and a lack of long-term outcome data.
Recommendation 13c covers patients who feel unwell on levothyroxine with a normal TSH. It finds insufficient evidence for a routine trial of combination therapy outside a formal clinical trial or an N-of-1 trial.
Recommendation 13d says the type 2 deiodinase gene variant should not be used to guide combination therapy.

The guideline is not dismissive of the biology. It notes that levothyroxine monotherapy produced low T3 levels "in either some or many patients," but "whether these altered biochemical parameters have clinical consequences is unknown." The ATA's current hypothyroidism patient page says some people "may also need a second medicine called liothyronine or T3 if they don't feel better with T4 alone." That decision rests on symptoms and TSH, not on an rT3 level.

What should you do if you have symptoms with a normal TSH?

Start with the guideline's own advice. Recommendation 9b of the 2014 ATA guideline states: "Acknowledgment of the patients' symptoms and evaluation for alternative causes is recommended in such cases." Your clinician should take the fatigue or brain fog seriously and look for other explanations. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) notes that "a hypothyroidism diagnosis can't be based on symptoms alone."

Practical steps:

Check the basics of your dose. NIDDK and the ATA both recommend a blood test about 6 to 8 weeks after starting or changing levothyroxine. Timing, food, and supplements affect absorption. See our levothyroxine guide.
Ask where your TSH sits in the range. This is a dose conversation, not an rT3 conversation.
Review medicines and illness. NIDDK notes that corticosteroids and severe illness can lower T4. MedlinePlus adds that "certain medicines and supplements can affect your test results."
Look beyond the thyroid. Anemia, vitamin deficiencies, sleep disorders, and depression can mimic hypothyroid symptoms. symptom.md covers fatigue with normal labs.

We cover this workup in why you still have symptoms when your TSH is normal. If you and your clinician try liothyronine, the ATA frames that as a structured trial with clear endpoints. An rT3 result is not what should trigger it.

The bottom line

Reverse T3 is the inactive product of type 3 deiodinase acting on T4. It rises during illness, fasting, and with drugs like amiodarone, glucocorticoids, and propranolol. It marks that shift; it does not cause symptoms. The ATA says the test "is not clinically useful" in non-hospitalized people, and no guideline recommends it. The 2014 ATA guideline keeps levothyroxine as the standard of care and asks clinicians to take unresolved symptoms seriously and search for other causes. If you feel unwell with a normal TSH, that search is where the answer is likely to be.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk with your clinician before changing any thyroid medication or ordering additional thyroid tests.